Yu.V. GARIFULLOVA

Kazan State Medical University, 49 Butlerov Str., Kazan, Russian Federation, 420012

Garifullova Yu.V. ― Assistant Lecturer of the Department of Obstetrics and Gynecology No. 1, tel. +7-919-637-22-33, e-mail: gamil.garifullov@yandex.ru

 The data were analyzed, presented in the Russian and foreign literature in the recent ten years and devoted to benign breast diseases (BBD). The possibilities of ultrasound, X-ray mammography and magnetic resonance imaging for the differential diagnosis of various forms of BBD and breast cancer are described. The importance of using the BI-RADS system in describing the results of radiation diagnostic methods of the breast is shown.

Key words: benign breast diseases, radiation diagnostic methods.

REFERENCES

1. Angela L.W. Meisner, MPH, M. HoumanFekrazad, MD, Melanie E. Royce, MD, PhD Breast Disease: Benign and Malignant, Med Clin N Am, 92 (2008) 1115–1141.
2. Dyrstad S.W., Yan Y., Fowler A.M., Colditz G.A. Breast canser risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res. Treat. 2015; 149(3): 135-40.
3. Lonzetta Neal M.D, Cindy L., Tortorelli M.D. and Aziza Nassar M.D. Clinician’s Guide to Imaging and Pathologic Findings in Benign Breast Disease Mayo, Clinic Proceedings, 2010-03-01, vol. 85, issue 3, pp. 274-279.
4. Ashbeck EL, Rosenberg RD, Stauber PM et al. Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev., 2007;16(3):467–72.
5. Zhirnova A.S., Shevlyuk N.N., Kurlaev P.P. Morphological features of breast tissue in women of different age groups in norm and in mastopathy. Zhurnal anatomii i gistopatologii, 2015, vol. 4, no. 4, pp. 34–38 (in Russ.).
6. Kharchenko V.P., Rozhkova N.I. Mammologiya. Natsional’noe rukovodstvo [Mammalogy. National leadership]. Moscow: GEOTAR-media, 2009. 328 p.
7. Werner J. Boecker David J. Dabbs Breast Pathology. Second Edition. Elsevier. 2017, pp. 373-395
8. Fisher U., Baum F. Mammografiya: 100 klinicheskikh sluchaev [Mammography: 100 clinical cases]. Moscow: MEDpress-inform, 2009. 368 p.
9. Martba B. Mainiero, Ana Lourenco, Mary C. Maboney et al. ACR appropriateness criteria for breast cancer screening. J. Am. Coll. Radiol. 2013; 10:11-14.
10. Shershneva M.A., Solodkiy V.A., Meskikh E.V.et al. The potential of SPECT / CT in refining diagnosis of the nodular formations of the mammary glands. Vestnik Rossiyskogo nauchnogo tsentra rentgenoradiologii Minzdrava Rossii, 2015, no. 3, p. 1 (in Russ.).
11. Bukharin D.G., Velichko S.A., Frolova I.G., Luneva S.V. Ultrasonography and X-ray mammography in the diagnosis of breast cancer that developed against the background of mastopathy. Sibirskiy meditsinskiy zhurnal, 2012, vol. 27, no.  1, pp. 99–102 (in Russ.).
12. D’Orsi C.J., Sickles E.A., Mendelson EB, Morris E.A. et al. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology; 2013.
13. Rinaldi P., Ierardi C., Costantini M. et al.Cystic breast lesions: sonographic findings and clinical management. J ultrasound Med., 2010, Nov.; 29(11): 1617-26.
14. Vincent Lavoue, Xavier Fritel Martine Antoine, Francoise Beltjens et al.Clinical practice guidelines from the French College of Gynecologistsand Obstetricians (CNGOF): benign breast tumors ― short text. European Journal of Obstetrics & Gynecology and Reproductive Biology 200 (2016) 16–23.
15. Ikeda, Debra M., MD, FACR, FSBI Breast Imaging: The requisites, Third Edition, Elsevier, 2017, cnh 171-219.
16. Wendie A. Berg, Zheng Zhang, Daniel Lehrer, Roberta A. Jong et al. Detection of Breast Cancer with Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women with Elevated Breast Cancer Risk. JAMA, April 4, 2012, vol 307, no. 13, pp. 1394-1404.
17. Richard G. Barr, Zheng Zhang, Jean B. Cormack, PhD, Ellen B. Mendelson Probably Benign lesions at screening Breast Us in a Population with elevated risk: Prevalence and Rate of Malignancy in the ACRIN 6666 Trial. Radiology, vol. 269, no. 3, December 2013, rr.701-712.
18. Wendie A. Berg, Alan G. Sechtin, Helga Marques and Zheng Zhang Cystic Breast Masses and the ACRIN 6666, Experience Radiologic Clinics of North America 2010-09-01, vol. 48, issue 5, pp. 931-987.
19. Shetty MK, Shan YP Sonographic findings in focal fibrocystic changes of the breast. Ultrasound Q, 2002, March; 18 (1): 35-40.
20. Rozhkova N.I., Zubarev A.V., Zapirova S.B. et al. New technology-sonoelastography in mammology. Meditsinskaya vizualizatsiya, 2010, no. 4, pp. 89–99 (in Russ.).
21. Molly A.B. Blank and James F. Antaki Breastlesion elastography region of interest selection and quantitative heterogeneity: a systematic review and meta-analysis. Ultrasound in Med. & Biol., 2017, vol. 43, no. 2, pp. 387–397.
22. Wendie A. Berg, Ellen B. Mendelson, David O. Cosgrove et al. Quantitative Maximum Shear Wave Stiffness of Breast Masses as a Predictor of Histopathologic Severity. AJR, 2015; 205:448–455 DOI:10.2214/AJR.14.13448.
23. Sonya D. Edwards, Jafi A. Lipson, Debra M. Ikeda, Janie M. Lee Updates and Revisions to the BI-RADS Magnetic Resonance Imaging Lexicon Magn Reson Imaging. Clin N Am, 21 (2013), 483–493.
24. Fisenko E.P., Mel’nikov D.V., Startseva O.I. et al. Liponecrosis of the breast: ultrasound masks. Ul’trazvukovaya i funktsional’naya diagnostika, 2015, no. 3, pp. 13–25 (in Russ.).
25. Rozhkova N.I., Prokopenko S.P., Mazo M.L. Features of radial ductal sonography of the mammary gland. Vestnik RNTsRR MZ RF, 2011, no. 11 (in Russ.), available at: http://vestnik.rncrr.ru/vestnik/v11/papers/mazo_v11.htm
26. Piccoli CW, Forsberg F. Advanced Ultrasound Techniques for Breast Imaging Seminars in Roentgenology, 2011, Jan;46(1): pp 60-7
27. Kogan I.Yu. Mastopathy: new approaches to diagnosis and pathogenetic therapy. Journal of Obstetrics and Women’s Diseases. Zhurnal akusherstva i zhenskikh bolezney, vol. LIX, iss. 1/2010, pp. 66-700 (in Russ.)
28. Padhmini Balasubramanian, Vijaya Karthikeyan Murugesan, Vinoth Boopathy The Role of MR Mammography in Differentiating Benign from Malignant in Suspicious Breast Masses. Journal of Clinical and Diagnostic Research, 2016, Sep, vol. 10(9): TC05-TC08.
29. Khoruzhik S.A., Shimanets S.V., Karman A.V., Shapoval E.V. Use of the BIRADS system to interpret the data of magnetic resonance mammography in breast cancer. Vestnik rentgenologii radiologii. 2014, no. 4, pp. 46-59 (in Russ.).
30. Palestrant S., Phila M., Christopher E., Comstock, Moy L. Approach to Breast Magnetic Resonance Imaging Interpretation. RadiolClin N Am., 52 (2014): 563–583.
31. Jeon-Hor Chen, Hui Liu, Hyeon-Man Baek et al. Magnetic resonance imaging features of fibrocystic change of the breast. Magnetic Resonance Imaging, 26 (2008) 1207–1214.

32.       Ochi M., Kuroiwa T., Sunami S., Murakami J. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes breast. Causer, 2013, Apr, 20 (2):137-44.